Drug
MR 146
MR 146: highest development phase Phase 1/2, developed by Viatris. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Viatris
Trials
| Drug | Phase | Indication |
|---|---|---|
| MR-146 NCT07923045 | Phase 1/2 | Neurotrophic Keratopathy |
Latest
No recent events.
Follow MR 146 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.